HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].

AbstractOBJECTIVE:
To investigate the difference of host immune response specific to hepatitis B virus (HBV) infections between acute self-limited and chronic persistent hepatitis by quantitative analysis of HLA-A * 2402-restricted HBcAg-specific cytotoxic T lymphocyte cells (CTL) cells.
METHODS:
The frequency of HBV-specific CTL cells in the peripheral blood mononuclear cells (PBMCs) from 20 patients infected with HBV were quantified by ELISPOT assays and flow cytometry using one HLA-A * 2402-HBV, 7 with acute HB and 13 with chronic HB, peptide tetrameric complex.
RESULTS:
High frequencies of circulating HBcAg-specific CTL cells were detected in most individuals with acute HBV infection while the number of these cells was significantly reduced at the convalescent stage. HBcAg-specific CTL cells were not detected in the PBMC from individuals with chronic HBV infection except for one patient with an acute infection exacerbation.
CONCLUSION:
HBcAg-specific CTL cells may play a crucial role in complete clearance of HBV from patients with acute HBV hepatitis.
AuthorsZhen-ping Fan, Fu-sheng Wang, Dong-Ping Xu, Fu-liang Chu, Ming Shi, Yu Zhou, Ling-xia Zhang
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 84 Issue 24 Pg. 2073-6 (Dec 17 2004) ISSN: 0376-2491 [Print] China
PMID15730619 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A Antigens
  • Hepatitis B Core Antigens
Topics
  • Adolescent
  • Adult
  • Female
  • HLA-A Antigens (immunology)
  • Hepatitis B (immunology)
  • Hepatitis B Core Antigens (immunology)
  • Hepatitis B, Chronic (immunology)
  • Humans
  • Male
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: